180 related articles for article (PubMed ID: 17290074)
1. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D
J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074
[No Abstract] [Full Text] [Related]
2. Are we cautious enough when we interpret results of randomized but underpowered comparisons?
Paesmans M; Bleiberg H
J Clin Oncol; 2006 Apr; 24(12):1964-5. PubMed ID: 16622279
[No Abstract] [Full Text] [Related]
3. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
Mooney MM; Schoenfeldt M
Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
[No Abstract] [Full Text] [Related]
4. Progression-free versus overall survival and adequate powering in randomised studies.
Manek N; Apostolopoulos C; Stebbing J
Eur J Cancer; 2008 Oct; 44(15):2092-4. PubMed ID: 18790634
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy for advanced colorectal cancer.
Mason M; Johnson P; Rudd R;
Br J Cancer; 2003 Apr; 88(7):1152-3; author reply 1153-5. PubMed ID: 12671718
[No Abstract] [Full Text] [Related]
6. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
Tang PA; Bentzen SM; Chen EX; Siu LL
J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
[TBL] [Abstract][Full Text] [Related]
7. On the relationship between response to treatment and survival time.
Buyse M; Piedbois P
Stat Med; 1996 Dec; 15(24):2797-812. PubMed ID: 8981687
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomized clinical trials in cancer.
Buyse M
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
[No Abstract] [Full Text] [Related]
9. The scientific basis of clinical trials: statistical aspects.
Gehan EA
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
[TBL] [Abstract][Full Text] [Related]
10. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
11. [Meta-analysis of clinical trials].
Pignon JP; Poynard T
Gastroenterol Clin Biol; 1991; 15(3):229-38. PubMed ID: 2044886
[No Abstract] [Full Text] [Related]
12. Statistical issues in interpreting clinical trials.
DeMets DL
J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in patients with colorectal carcinoma: applicability of data from clinical trials for the individual patient].
Thürmann PA
Zentralbl Chir; 2008 Feb; 133(1):25-30. PubMed ID: 18278698
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
Atkins DC
Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
[No Abstract] [Full Text] [Related]
15. [Palliative chemotherapy in patients with metastatic colorectal cancer].
Jensen TS
Ugeskr Laeger; 2002 Jan; 164(4):474-6. PubMed ID: 11838416
[No Abstract] [Full Text] [Related]
16. Validity of the MAGIC study: sufficient for recommendations?
Bauer K; Porzsolt F; Henne-Bruns D
Hepatogastroenterology; 2013 Oct; 60(127):1822-4. PubMed ID: 24624448
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
18. Fallacies in clinical cardiovascular trials.
Swedberg K
Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
[No Abstract] [Full Text] [Related]
19. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
Davies SJ
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
[No Abstract] [Full Text] [Related]
20. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
Punt CJ; Koopman M
J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
